GETI-B:STO
Getinge publ AB
SEK 248.00
arrow_upward
+0.36%(+0.90) 1D
Sep 30, 5:29:47 PM GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GETI-B...
Open
SEK 248.90
High
SEK 249.80
Low
SEK 247.10
Mkt. cap
63.03B
Avg. vol.
567.35K
Volume
0.00
Dividend
1.92%
Quarterly dividend
SEK 1.19
Ex-dividend date
Apr 22, 2026
P/E ratio
25.26
52-wk high
SEK 251.40
52-wk low
SEK 175.90
EPS
SEK 9.82
Shares outstanding
254.15M
No. of employees
12K
Open
SEK 248.90
High
SEK 249.80
Low
SEK 247.10
Mkt. cap
63.03B
Avg. vol.
567.35K
Volume
0.00
Dividend
1.92%
Quarterly dividend
SEK 1.19
Ex-dividend date
Apr 22, 2026
P/E ratio
25.26
52-wk high
SEK 251.40
52-wk low
SEK 175.90
EPS
SEK 9.82
Shares outstanding
254.15M
No. of employees
12K
News stories
From web sources and news partners
AD HOC NEWS
·
12 hours ago
Pareto downgrades Getinge and keeps Getinge stock target at SEK 255.00
AD HOC NEWS
·
2 days ago
Getinge B stock rises 2.35 percent as analyst caution returns
Profile
Getinge AB is a publicly traded Swedish medical technology company. The company produces and distributes medical products and equipment for the healthcare and life sciences industries. The company is divided into three business areas: Life Science, Acute Care Therapies, and Surgical Workflows. The group employs approximately 12,000 people worldwide. The CEO of the company is Mattias Perjos, and the chairman of the board is Johan Malmquist. With a sales share of around 40%, the United States is by far the most important market for the company due to significantly higher prices and margins there. China and various Western European countries follow. Wikipedia
About Getinge publ AB